Polyarthrite rhumatoïde de l'adulte, épidémiologie, clinique et diagnostic. DIU Etude approfondie des polyarthrites et maladies systémiques, 2016. ,
Early rheumatoid arthritis: strategies for prevention and management, Best Pract Res Clin Rheumatol, vol.21, issue.1, pp.27-42, 2007. ,
Prevalence of rheumatoid arthritis in France, Ann Rheum Dis, vol.64, issue.10, pp.1427-1457, 2001. ,
Immunopathologie de la polyarthrite rhumatoïde, DIU Etude approfondie des polyarthrites et maladies systémiques. 2016. cours n°3 ,
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative, Ann Rheum Dis, vol.69, issue.9, pp.1580-1588, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01557559
Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study, Rheumatology (Oxford), vol.38, issue.11, pp.1138-1179, 1999. ,
Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis, J Rheumatol, vol.30, issue.11, pp.2344-2353, 2003. ,
Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study, Arthritis Rheum, vol.50, issue.7, pp.2072-81, 2004. ,
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Ann Rheum Dis, vol.66, issue.1, pp.34-45, 2007. ,
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials, Arthritis Rheum, vol.63, issue.3, pp.573-86, 2011. ,
Development and validation of the European League against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League against Rheumatism Criteria, Arthritis Rheum, vol.39, issue.1, pp.34-40, 1996. ,
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Ann Rheum Dis, vol.66, issue.1, pp.34-45, 2007. ,
Quality of life and obesity, Obes Rev, vol.2, pp.2-19, 2001. ,
Body mass index and mortality in a prospective cohort of US adults, N Engl J, vol.341, pp.1097-105, 1999. ,
Overweight, obesity and mortality in a large prospective cohort of persons 50 to 71 years old, N Engl J Med, vol.355, pp.763-78, 2006. ,
, Overweight / Obesity: Overweight (body mass index >25) by country. World Health Organisation -Global Health Observatory Data Repository, 2016.
Obesity in rheumatoid arthritis, Rheumatology (Oxford), vol.50, pp.450-62, 2011. ,
The impact of obesity on the developpement and progression of rheumatoid arthritis, Ann Rheum Dis, vol.73, pp.1911-1913, 2014. ,
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST -RA study, Arthritis Res Ther, vol.10, p.30, 2008. ,
Obesity ans cardiovascular risk factors factors in rheumatoid arthritis, Rheumatology (Oxford), vol.45, p.782, 2006. ,
Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study, Ann Rheum Dis, vol.73, pp.1914-1922, 2014. ,
Association of obesity with worse disease severity in rheumatoid arthritis as well as witrh comorbidities: a long-term followup from disease onset, Arthritis Care Res (Hoboken), vol.65, pp.78-87, 2013. ,
Impact of obesity on remission and disease activity in rheumatoid arthritis: a systematic review and meta-analysis, Arthritis Care Res (Hoboken), vol.69, issue.2, pp.157-165, 2017. ,
A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis, Ann Rheum Dis, vol.67, pp.769-74, 2008. ,
Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients, Arthritis Care Res, vol.65, pp.1235-1277, 2013. ,
Body mass index and clinical response to infliximab in rheumatoid arthritis, Arthritis Rheum, vol.63, pp.359-64, 2011. ,
Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index, Arthritis Rheum, vol.56, pp.3575-82, 2007. ,
Cortisol metabolism in obesity, J Clin Endocrinol Metab, vol.24, pp.832-873, 1964. ,
Adipocytokines: mediators linking adipose tissue, inflammation and immunity, Nat Rev Immunol, vol.6, pp.772-83, 2006. ,
Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis, Arthritis Rheum, vol.60, pp.1906-1920, 2009. ,
Elevated levels of interleukin 6 are reduced in serumand subcutaneous adipose tissue of obese women after weight loss, J Clin Endocrinal Metab, vol.85, pp.3348-3390, 2000. ,
Elevated C-reactive protein levels in overweight and obese adults, JAMA, vol.282, pp.2131-2136, 1999. ,
Obesity and reduction of the response rate to anti-tumor necrosis factor alpha in rheumatoid arthritis: an approach to a personalized medicine, Arthritis Care Res, vol.65, pp.94-100, 2013. ,
Body mass index and response to abatacept in rheumatoid arthritis, Eur J Clin Invest, vol.46, issue.12, pp.1048-1052, 2016. ,
Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study, Clin Rheumatol, vol.35, pp.857-61, 2016. ,
Smoking and overweight determine the likelihood of developing rheumatoid arthritis, Ann Rheum Dis, vol.72, pp.1654-1662, 2013. ,
Adipokines in inflammation and metabolic disease, Nat Rev Immunol, vol.11, pp.85-97, 2011. ,
Rheumatoid arthritis: the multifaceted role of adiponectin in inflammatory joint disease, Nat Rev Rheumatol, vol.5, pp.659-60, 2009. ,
Adipocytokines-novel link between inflammation and vascular function?, J Physiol Pharmacol, vol.57, pp.505-533, 2006. ,
Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis, Epidemiology, vol.5, pp.525-557, 1994. ,
Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results for a primary care-based incident case control study in, Arthritis Rheum, vol.40, pp.1955-61, 1997. ,
A high body mass index is associated with reduced risk of rheumatoid arthritis in men, but not in women, Rheumatology (oxford), vol.55, pp.307-314, 2016. ,
The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis, J Res Med Sci, vol.19, pp.509-523, 2014. ,
Underweight and obese states both ascociate with worse disease activity and physical function in patients with established rheumatoid arthritis, Clin Rheumatol, vol.28, pp.439-483, 2009. ,
Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis, Clin Rheumatol, vol.26, pp.1831-1836, 2007. ,
Overweigt decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis, Ann Rheum Dis, vol.73, pp.2029-2062, 2014. ,
Response to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient, J Rheumatol, vol.42, pp.580-584, 2015. ,
Eular recommandations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs, Ann Rheum Dis, vol.69, pp.964-75, 2010. ,
Recommandations de la société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoide, Rev Rhum, vol.81, pp.303-315, 2014. ,
Van der Helmvan Mil A. Predicting arthritis outcomes -what can be learned from the Leiden early arthritis clinic ?, Rheumatology (Oxford), vol.50, pp.93-100, 2011. ,
Effect of obesity on the pharmacokinetics of drugs in humans, Clin Pharmacokinet, vol.49, pp.71-87, 2010. ,
Body Mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA, Clin Rheumatol, 2016. ,
Evolution de la densité minérale osseuse au cours de la polyarthrite rhumatoide sous biothérapie versus sans biothérapie -Suivi à 8 ans. Publication en cours 54. WHO. Obesity: preventing and managing the global epidemic, Technical Report Series, p.894, 2000. ,
Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis, Arthritis Care Res (Hubocan), vol.65, pp.141-148, 2013. ,
Obesity is associated with en lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis, Ann Rheum Dis, vol.74, pp.813-820, 2015. ,
Body mass index influences the response to infliximab in ankylosing spondylitis, Arthritis Res Ther, vol.14, p.115, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00704843
Body weight, gender and response to TNF alpha blockers in axial spondyloarthritis, Rheumatology (Oxford), vol.53, pp.875-81, 2014. ,
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis: An Observational Study, Medicine (Baltimore), vol.94, issue.21, p.888, 2015. ,
Targeting obesity, insulin resistance and type 2 diabetes with immunotherapy: the challenges ahead, Immunotherapy, vol.6, pp.5-7, 2014. ,
Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis, Arthritis Res Ther, vol.14, p.160, 2012. ,
Bariatric surgery and Rheumatic diseases: a literature review, Rev Recent Clin Trials, 2018. ,
Obesity and response to anti-tumor necrosis factoragents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis, PLoS One, vol.13, issue.5, p.195123, 2018. ,
Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis, J Eur Acad Dermatol Venereol, vol.31, issue.3, pp.490-497, 2017. ,